Clinical Trial Update: Prospective Evaluation of Airways Reactivity

View source ↗

Summary

Completed prospective evaluation of airway reactivity sponsored by NHLBI, examining conditions such as asthma and obstructive lung diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Obstructive Lung Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Asthma | Status: COMPLETED